Form4insider filings, from the source

Insider holders · CIK 0001358403

BELLICUM PHARMACEUTICALS, INC · BLCM

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Kevin M. SlawinDirector84,206398,067482,273Feb 9, 2017 · 4:11 pm ESTForm 4
David M. SpencerChief Technology Officer92,470—92,470Jan 4, 2019 · 4:02 pm ESTForm 4
Thomas J. FarrellPresident and CEO63,862—63,862Oct 6, 2015 · 6:11 am EDTForm 4
Baker Bros. Advisors (GP) LLC10% Owner—58,13158,131Jan 19, 2018 · 4:57 pm ESTForm 4
BAKER BROS. ADVISORS LP10% Owner—58,13158,131Jan 19, 2018 · 4:57 pm ESTForm 4
Felix Baker10% Owner—58,13158,131Jan 19, 2018 · 4:57 pm ESTForm 4
Julian Baker10% Owner—58,13158,131Jan 19, 2018 · 4:57 pm ESTForm 4
William GrossmanSr. VP, Chief Medical Officer26,874—26,874Feb 7, 2019 · 4:02 pm ESTForm 4
Alan A MussoCFO and Treasurer26,548—26,548May 29, 2018 · 4:49 pm EDTForm 4
Gregory S. NaeveChief Business Officer14,441—14,441Jan 4, 2019 · 4:03 pm ESTForm 4
Shane WardSr. VP and General Counsel10,000—10,000May 29, 2018 · 9:29 pm EDTForm 4
Jon P StonehouseDirector10,000—10,000Nov 13, 2018 · 4:01 pm ESTForm 4
Alan K. SmithEVP, Technical Operations4,521—4,521Jan 4, 2019 · 4:01 pm ESTForm 4
Aaron E. FosterSr VP, Head of Research3,737—3,737Feb 20, 2019 · 4:01 pm ESTForm 3
Ken MoseleySr. VP and General Counsel1,4652,1933,658Jan 5, 2018 · 4:03 pm ESTForm 4
Rosemary Y. WilliamsPrincipal Accounting Officer3,186—3,186Jan 4, 2019 · 4:04 pm ESTForm 3
Annemarie MoseleyCOO/EVP Clinical Development442—442Dec 5, 2016 · 4:07 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.